Obstructive Sleep Apnea Hypopnea, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), is a significant sleep disorder characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep (American Psychiatric Association [APA], 2023). This obstruction leads to a reduction (hypopnea) or cessation (apnea) of airflow despite ongoing respiratory efforts. Individuals with this disorder typically present with loud snoring, observed episodes of breathing cessation during sleep, abrupt awakenings accompanied by gasping or choking, and excessive daytime sleepiness. These symptoms are often more pronounced in individuals who are overweight or have anatomical variations in the neck and throat area.

Further characterizing the disorder, patients may experience morning headaches, difficulty concentrating, mood disturbances such as irritability or depression, and a decrease in libido. The recurrent awakenings and fragmented sleep patterns contribute to excessive daytime sleepiness, which can significantly impair an individual's ability to function in daily activities and increase the risk of accidents, particularly while driving.

The pathophysiology of Obstructive Sleep Apnea Hypopnea involves the relaxation of muscles in the throat during sleep, which leads to a narrowed airway. This narrowing can cause significant reductions in blood oxygen levels, triggering the body's reflex to awaken briefly to reopen the airway. This cycle can occur dozens or even hundreds of times per night, significantly disrupting the normal sleep architecture.

While the DSM-5-TR outlines the clinical features and diagnostic criteria for Obstructive Sleep Apnea Hypopnea, it emphasizes the importance of a thorough medical evaluation to rule out other potential causes of the observed symptoms and to confirm the diagnosis with a sleep study, such as polysomnography. This comprehensive approach ensures accurate diagnosis and appropriate management of the condition.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) does not specifically list diagnostic criteria for Obstructive Sleep Apnea Hypopnea (OSAH). OSAH is primarily diagnosed and categorized based on medical and sleep-specific diagnostic criteria, such as those outlined in the International Classification of Sleep Disorders, Third Edition (ICSD-3), and not typically in the DSM-5-TR, which focuses more on mental health disorders (APA, 2023).

However, it's important to note that the DSM-5-TR does acknowledge sleep-wake disorders and highlights the significance of sleep in overall mental health. It also acknowledges the comorbidity of sleep disorders with psychiatric conditions. For the diagnosis of sleep disorders like OSAH, the DSM-5-TR defers to the ICSD or other medical diagnostic tools.

In the context of the ICSD-3 and other medical literature, the diagnosis of OSAH is usually based on a combination of patient-reported symptoms and objective findings from a sleep study, such as polysomnography. Key symptoms include loud snoring, observed episodes of stopped breathing during sleep, abrupt awakenings accompanied by shortness of breath, morning headache, difficulty staying asleep, excessive daytime sleepiness, attention or concentration problems, and sometimes mood disturbances.

The definitive diagnosis is usually made through polysomnography, which measures various physiological parameters during sleep. Criteria include several apneic and hypopneic episodes per hour of sleep (Apnea-Hypopnea Index or AHI), with thresholds set for mild, moderate, and severe OSAH. These thresholds are based on extensive research correlating AHI levels with clinical symptoms and outcomes.

For instance, a study by Young et al. (1993) found a strong correlation between the severity of OSAH (as measured by AHI) and the presence of daytime sleepiness, hypertension, and other cardiovascular risks. Another study by Peppard et al. (2000) linked moderate to severe OSAH with a significant increase in the risk of developing hypertension, independent of other risk factors.

In the DSM-5-TR (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), while Obstructive Sleep Apnea Hypopnea (OSAH) is not specifically detailed with its own set of diagnostic criteria or specifiers, the manual does provide a framework for identifying and classifying sleep-wake disorders, which includes conditions like OSAH. The DSM-5-TR recognizes the significant impact of sleep disorders on mental health and the importance of their accurate diagnosis, often in conjunction with other medical diagnostic tools and criteria.

For a more detailed classification and specifiers of OSAH, professionals typically refer to the International Classification of Sleep Disorders, Third Edition (ICSD-3), published by the American Academy of Sleep Medicine. The ICSD-3 provides comprehensive criteria for sleep disorders, including OSAH, and is the standard reference used by sleep medicine specialists.

The specifiers in the context of OSAH typically include:

• Severity: OSAH is often categorized based on the severity of the condition, which is usually determined by the Apnea-Hypopnea Index (AHI) measured during a sleep study (polysomnography). The AHI indicates the number of apnea and hypopnea events per hour of sleep, with higher values indicating more severe OSAH.
• Presence of Symptoms: Specifiers may also include the presence or absence of critical symptoms such as excessive daytime sleepiness, fatigue, cognitive disturbances, or mood disorders.
• Associated Medical Conditions: Specifiers might include associated conditions such as hypertension, cardiovascular disease, or type 2 diabetes, which are often linked with OSAH.
• Risk Factors: These could include obesity, age, gender, and anatomical features that predispose an individual to OSAH.

The DSM-5-TR’s primary focus on mental health conditions means that it does not delve into the detailed classification of sleep disorders like OSAH, which are more thoroughly covered in medical diagnostic manuals dedicated to sleep medicine. While the DSM-5-TR recognizes the impact of sleep disorders on mental health, it does not provide specific diagnostic criteria for OSAH, deferring instead to sleep-specific diagnostic manuals and tools.

The Impacts

Obstructive Sleep Apnea Hypopnea (OSAH) is a significant sleep disorder with a wide range of impacts on both physical and mental health. Research has extensively documented these impacts, emphasizing the importance of early diagnosis and effective management.

One of the primary impacts of OSAH is on cardiovascular health. A seminal study by Peppard et al. (2000) found that moderate to severe OSAH was associated with a significantly increased risk of developing hypertension, independent of other known risk factors. This study, involving a large cohort, demonstrated a dose-response relationship between the severity of OSAH and the risk of hypertension. Similarly, other studies have linked OSAH with increased risks of heart failure, arrhythmias, and coronary artery disease, indicating a broad impact on cardiovascular health.

Neurocognitive effects are another significant concern. A study by Beebe and Gozal (2002) showed that OSAH could impair executive functioning, attention, and memory. These cognitive deficits are thought to result from the fragmented sleep and intermittent hypoxia characteristic of OSAH. This has considerable implications, particularly in occupational and academic settings, where cognitive functions are critical.

Furthermore, OSAH has been associated with metabolic issues. Research by Foster et al. (2009) demonstrated a link between OSAH and insulin resistance independent of obesity. This finding is significant given the global increase in diabetes and metabolic syndrome. The study suggests that OSAH may contribute to the development of these metabolic disorders.

In terms of mental health, OSAH is known to be associated with mood disturbances. A study by Bardwell et al. (2003) found a strong correlation between OSAH and depression, highlighting that the chronic sleep disruption and hypoxia experienced by individuals with OSAH can have profound effects on mood and mental well-being.

Lastly, OSAH can significantly impact quality of life. Daytime sleepiness, a common symptom, can lead to difficulties in daily functioning, increased risk of accidents, particularly driving accidents, and overall reduced life satisfaction.

These studies underscore the multifaceted impact of OSAH, highlighting the need for comprehensive approaches to diagnosis and management.

The Etiology (Origins and Causes)

The etiology of Obstructive Sleep Apnea Hypopnea (OSAH) is multifactorial, involving a complex interplay of anatomical, physiological, and genetic factors. Extensive research has been conducted to understand the origins and causes of this condition.

Anatomical factors play a crucial role in the development of OSAH. A study by Schwab et al. (2003) used magnetic resonance imaging (MRI) to demonstrate that individuals with OSAH often have anatomical differences in their upper airway structures, such as enlarged tonsils, a longer soft palate, or a smaller lateral pharyngeal wall. These structural variations can narrow the airway, increasing the likelihood of obstruction during sleep.

Physiological factors, including the functionality of the upper airway muscles, are also significant. Eckert et al. (2007) found that reduced muscle responsiveness during sleep in individuals with OSAH contributes to airway collapse. This reduced muscle tone, particularly during the rapid eye movement (REM) stage of sleep, exacerbates the risk of apnea episodes.

Obesity is another significant risk factor for OSAH, as highlighted by a study from Peppard et al. (2000). Fat accumulation around the neck and throat can further narrow the airway, increasing the likelihood of obstruction. This study also pointed out that even a moderate weight gain can significantly increase the risk of developing OSAH.

Genetic predisposition is also a factor in OSAH. A study by Palmer et al. (2004) identified several genetic markers associated with an increased risk of OSAH. These genetic factors may influence craniofacial structure, fat distribution, and neuromuscular control, all of which can contribute to the development of OSAH.

Lifestyle factors, such as alcohol consumption and smoking, have also been implicated in the etiology of OSAH. A study by Wetter et al. (1994) found that alcohol relaxes the muscles of the throat, exacerbating airway obstruction during sleep, while smoking can lead to inflammation and fluid retention in the upper airway.

OSAH is a complex disorder with multiple contributing factors, including anatomical variations, physiological characteristics, obesity, genetic predisposition, and lifestyle choices.

Comorbidities

Obstructive Sleep Apnea Hypopnea (OSAH) is associated with various comorbidities affecting various health aspects. The research literature extensively documents these associations, highlighting the interplay between OSAH and other health conditions.

Cardiovascular diseases are among the most significant comorbidities of OSAH. A landmark study by Peppard et al. (2000) demonstrated a strong association between OSAH and the development of hypertension. This prospective study, which followed participants over several years, found that individuals with moderate to severe OSAH had a significantly higher risk of developing hypertension, independent of other known risk factors. Furthermore, a study by Marin et al. (2005) linked OSAH with an increased risk of fatal and nonfatal cardiovascular events, emphasizing the severe impact of OSAH on cardiovascular health.

Metabolic syndrome and type 2 diabetes are also commonly associated with OSAH. In a study by Foster et al. (2009), OSAH was shown to be significantly associated with insulin resistance and glucose intolerance, which are critical components of metabolic syndrome. This relationship was observed even after adjusting for obesity, suggesting an independent link between OSAH and metabolic dysregulation.

Neurocognitive impairments are also a notable comorbidity. A study by Beebe and Gozal (2002) found that OSAH can lead to deficits in executive function, attention, and memory. These impairments are thought to be a consequence of the disrupted sleep architecture and intermittent hypoxia characteristic of OSAH.

Mood disorders, particularly depression, have been frequently observed in individuals with OSAH. Bardwell et al. (2003) conducted a study demonstrating a significant correlation between OSAH and depressive symptoms. The chronic sleep disruption and the physiological stress associated with OSAH are believed to contribute to this relationship.

Additionally, OSAH is associated with an increased risk of motor vehicle accidents, as highlighted in a study by Tregear et al. (2009). This increased risk is attributed to the excessive daytime sleepiness that is a common symptom of OSAH.

These studies collectively illustrate the wide-ranging impact of OSAH on health, underscoring the importance of its recognition and management in clinical practice.

Risk Factors

The risk factors for Obstructive Sleep Apnea Hypopnea (OSAH) are diverse, encompassing modifiable and non-modifiable elements. Research has identified several key factors that increase the likelihood of developing OSAH.

Obesity is one of the most significant risk factors for OSAH. A study by Young et al. (2002) highlighted the strong association between body mass index (BMI) and OSAH, finding that individuals with higher BMIs were at a substantially increased risk. This is attributed to fat deposition around the neck and upper airway, leading to airway obstruction during sleep.

Age is another critical factor. Ancoli-Israel et al. (1991) found that the prevalence of OSAH increases with age, possibly due to the loss of muscle tone and increased soft tissue around the airway in older individuals. However, it's important to note that OSAH can occur at any age.

Gender also plays a role. Peppard et al. (2000) observed that men are more likely to develop OSAH than women, especially in younger age groups. This disparity is related to differences in fat distribution, hormonal factors, and airway anatomy between men and women.

Anatomical features of the upper airway and craniofacial structure are also significant. Schwab et al. (2003) used MRI to demonstrate that individuals with OSAH often have anatomical differences, such as a larger tongue, elongated soft palate, and narrower airway, which predispose them to airway obstruction during sleep.

Family history and genetics are also recognized as risk factors. A study by Redline et al. (1995) suggested a genetic predisposition to OSAH, finding that having a family member with OSAH increases one's risk of developing the condition.

Lifestyle factors, such as alcohol consumption and smoking, have been implicated in OSAH. Wetter et al. (1994) found that alcohol and sedatives relax the muscles of the throat, exacerbating airway obstruction, while smoking can lead to inflammation and fluid retention in the upper airway.

In summary, OSAH risk factors are multifaceted, involving a combination of physical, genetic, and lifestyle factors. Understanding these risks is crucial for prevention and early intervention strategies.

Case Study

Presenting Concerns: Marco, a 55-year-old accountant, presented to the clinic with complaints of chronic daytime fatigue and unrefreshing sleep. He reported frequent loud snoring, as witnessed by his spouse, and instances of gasping for air during the night. Marco also mentioned experiencing morning headaches and difficulty concentrating at work.

Medical and Psychosocial History: Marco has a history of hypertension, managed with medication. He is overweight, with a BMI of 30. No history of psychiatric conditions was reported. He lives with his wife and has two adult children. Marco described his work environment as stressful, and he occasionally consumes alcohol in the evenings to relax.

Assessment: A comprehensive evaluation was conducted, including a physical examination, a review of medical history, and a sleep questionnaire. Given the clinical presentation, a polysomnography (sleep study) was recommended to assess for Obstructive Sleep Apnea Hypopnea (OSAH).

Findings: The polysomnography revealed frequent apneic and hypopneic episodes, with an Apnea-Hypopnea Index (AHI) of 22 events per hour, indicating moderate OSAH. Marco's oxygen saturation levels dropped significantly during these episodes.

Diagnosis: Based on the DSM-5-TR framework for sleep-wake disorders and the findings from the sleep study, Marco was diagnosed with moderate Obstructive Sleep Apnea Hypopnea.

Treatment and Management:

• Continuous Positive Airway Pressure (CPAP) Therapy: Marco was advised to start CPAP therapy to maintain airway patency during sleep.
• Weight Management: A referral to a nutritionist was made to assist Marco in developing a weight loss plan.
• Lifestyle Modifications: Marco was counseled on sleep hygiene, the importance of regular exercise, and limiting alcohol consumption, especially before bedtime.
• Monitoring and Follow-up: Regular follow-up appointments were scheduled to monitor Marco's response to CPAP therapy and his progress with lifestyle modifications.
• Psychological Support: Given the impact of chronic fatigue on Marco's mood and cognitive functioning, a referral to a psychologist was made for supportive counseling.

Prognosis: With adherence to CPAP therapy and lifestyle changes, Marco’s symptoms are expected to improve significantly. Ongoing monitoring and adjustments to his treatment plan will be necessary to ensure long-term management of his OSAH.

Conclusion: This case highlights the importance of a comprehensive approach in diagnosing and managing Obstructive Sleep Apnea Hypopnea, considering medical and psychosocial aspects to optimize patient outcomes.

Recent Psychology Research Findings

Obstructive Sleep Apnea Hypopnea (OSAH) has been extensively studied in the field of psychology, focusing on its impact on cognitive, emotional, and behavioral aspects. A body of research has emerged, providing valuable insights into the psychological ramifications of this sleep disorder.

One significant area of research is the impact of OSAH on cognitive functioning. A study by Beebe and Gozal (2002) demonstrated that individuals with OSAH often experience cognitive deficits, including memory, attention, and executive functioning impairments. These impairments were linked to the fragmented sleep and intermittent hypoxia characteristic of OSAH, suggesting that the disrupted sleep architecture and oxygen deprivation play a crucial role in cognitive decline.

Another critical aspect is the relationship between OSAH and mood disorders. Bardwell et al. (2003) conducted research indicating a significant association between OSAH and depressive symptoms. The study suggested that the chronic sleep disruption and the physiological stress associated with OSAH contribute to the development of depressive states. This relationship highlights the need for comprehensive treatment approaches that address both the physiological and psychological aspects of OSAH.

The behavioral impacts of OSAH have also been a focus of research. Aloia et al. (2005) studied the effects of OSAH on daily functioning and quality of life. Their findings indicated that individuals with OSAH often experience significant daytime sleepiness, leading to decreased productivity, increased risk of accidents, and impaired social and occupational functioning. These behavioral impacts underscore the far-reaching effects of OSAH beyond mere sleep disturbance.

Additionally, research has explored the effects of treatment for OSAH on psychological outcomes. Continuous Positive Airway Pressure (CPAP) therapy, a common treatment for OSAH, has been shown to improve sleep quality and cognitive and emotional functioning. Weaver et al. (2007) found that adherence to CPAP therapy led to significant improvements in cognitive performance and mood, emphasizing the importance of treatment adherence in managing the psychological aspects of OSAH.

These studies collectively highlight the multifaceted impact of OSAH on psychological functioning, emphasizing the importance of considering psychological factors in the diagnosis and treatment of this sleep disorder.

Treatment and Interventions

The treatment and interventions for Obstructive Sleep Apnea Hypopnea (OSAH) encompass a range of approaches, including lifestyle modifications, mechanical therapies, and surgical options. These treatments are supported by a robust body of research, emphasizing their efficacy in managing the condition.

One of the primary treatments for OSAH is Continuous Positive Airway Pressure (CPAP) therapy. CPAP is a mechanical intervention that delivers a steady stream of air through a mask to keep the airway open during sleep. A landmark study by Sullivan et al. (1981) was among the first to demonstrate the effectiveness of CPAP in reducing apneic events and improving oxygen saturation levels. Later research by Weaver et al. (2007) further confirmed the benefits of CPAP, showing improvements in daytime sleepiness, cognitive function, and quality of life in patients with OSAH.

Lifestyle modifications are also critical in managing OSAH. Weight loss is particularly effective for overweight or obese individuals. A study by Foster et al. (2009) found that even modest weight loss could significantly improve OSAH severity. Additionally, avoiding alcohol and sedatives, which can relax the muscles of the throat and exacerbate airway obstruction, is recommended.

Oral appliance therapy is another treatment option, especially for patients with mild to moderate OSAH. Gotsopoulos et al. (2002) showed that oral appliances, which reposition the lower jaw and tongue to keep the airway open, can effectively reduce the frequency of apneas and hypopneas and improve oxygen saturation levels.

Surgical interventions, such as uvulopalatopharyngoplasty (UPPP), are considered when other treatments are ineffective or not tolerated. A study by Sher et al. (1996) evaluated the long-term outcomes of UPPP, showing a significant reduction in symptoms for a subset of patients. However, it's noted that surgical success rates can vary.

In some cases, positional therapy may be recommended. This involves training patients to avoid sleeping on their back, as OSAH symptoms can be more severe in this position. A study by Cartwright (1984) found that positional therapy could be an effective treatment for some patients with positional OSAH.

These diverse treatment options highlight the importance of individualized care in managing OSAH, with choices often based on the severity of the condition, patient preference, and comorbidities.

Implications if Untreated

Untreated Obstructive Sleep Apnea Hypopnea (OSAH) can have severe and wide-ranging implications for both physical and mental health, as documented in numerous studies.

Cardiovascular risks are among the most severe consequences of untreated OSAH. A landmark study by Peppard et al. (2000) found that untreated moderate to severe OSAH significantly increases the risk of developing hypertension. This study was crucial in establishing the link between sleep apnea and cardiovascular disease. Additionally, Marin et al. (2005) reported that untreated severe OSAH was associated with an increased risk of fatal and nonfatal cardiovascular events, including heart attacks and strokes, underscoring the severity of leaving this condition untreated.

Metabolic complications are also a concern. A study by Foster et al. (2009) showed that untreated OSAH is associated with an increased risk of developing insulin resistance and type 2 diabetes, independent of obesity. This finding highlights the role of OSAH in metabolic dysregulation and the importance of treatment in mitigating these risks.

Neurocognitive and psychological impacts of untreated OSAH are also significant. Beebe and Gozal (2002) demonstrated that OSAH can impair memory, attention, and executive functioning. These cognitive deficits are attributed to the interrupted sleep and intermittent hypoxia experienced by individuals with OSAH. Furthermore, untreated OSAH is linked to an increased risk of depression and anxiety, as indicated by a study by Bardwell et al. (2003), which found a strong correlation between OSAH and depressive symptoms.

Accidents and decreased quality of life are other important implications. Tregear et al. (2009) conducted a systematic review and meta-analysis showing that untreated OSAH increases the risk of motor vehicle accidents due to excessive daytime sleepiness. Additionally, OSAH can decrease work productivity and impair social relationships, impacting overall life satisfaction and well-being.

These studies illustrate the critical importance of diagnosing and treating OSAH to prevent these severe and multifaceted health consequences.

Summary

The understanding and managing Obstructive Sleep Apnea Hypopnea (OSAH) have evolved significantly over the years, reflecting a growing recognition of its complexity and multifaceted impact on individuals' lives. Historically, OSAH was primarily viewed through the lens of its physical health implications, particularly concerning cardiovascular risks. However, contemporary perspectives have broadened to encompass its psychological, social, and relational dimensions.

Initially, OSAH was often undiagnosed or misdiagnosed, as the awareness of the condition was limited, and symptoms were frequently attributed to other causes. With advancements in research and technology, especially since the 1980s, there has been a significant increase in the understanding of OSAH. Studies like those conducted by Sullivan et al. (1981) pioneered the exploration of effective treatments like CPAP therapy, marking a turning point in the management of OSAH.

The impact of OSAH on personal identity, relationships, and daily functioning has also gained attention. Research by Cartwright (2008) highlighted the potential for relationship disruption due to symptoms like loud snoring and restlessness, which can affect the sleep quality of partners. This can lead to bedroom separations and strained relationships, impacting the social and emotional well-being of both patients and their partners.

The psychological and emotional toll of OSAH, including its impact on self-esteem and confidence, has been increasingly recognized. Studies like those by Bardwell et al. (2003) have shown that chronic sleep disruption and the associated daytime fatigue can lead to feelings of inadequacy and frustration, impacting individuals' work performance and social interactions.

Moreover, OSAH's impact on identity is profound. The disorder can lead to reevaluating one's health and lifestyle choices, often necessitating significant adjustments. The management of OSAH, particularly with devices like CPAP, can also affect self-perception and body image.

In summary, the perspective on OSAH has evolved to become more inclusive and compassionate, acknowledging not only the physical but also the psychological and social challenges faced by those with the disorder. This holistic view emphasizes the importance of comprehensive treatment approaches that address the full spectrum of impacts associated with OSAH.

References

Aloia, M. S., Arnedt, J. T., Davis, J. D., Riggs, R. L., & Byrd, D. (2005). Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: A critical review. Journal of the International Neuropsychological Society, 11(5), 605-617.

American Academy of Sleep Medicine. (2014). International classification of sleep disorders (3rd ed.).

Ancoli-Israel, S., Kripke, D. F., Klauber, M. R., Mason, W. J., Fell, R., & Kaplan, O. (1991). Sleep-disordered breathing in community-dwelling elderly. Sleep, 14(6), 486-495.

Bardwell, W. A., Moore, P., Ancoli-Israel, S., & Dimsdale, J. E. (2003). Fatigue in obstructive sleep apnea: Driven by depressive symptoms instead of apnea severity? American Journal of Psychiatry, 160(2), 350-355.

Beebe, D. W., & Gozal, D. (2002). Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. Journal of Sleep Research, 11(1), 1-16.

Cartwright, R. (2008). Sleeping together: A pilot study of the effects of shared sleeping on adherence to CPAP treatment in obstructive sleep apnea. Journal of Clinical Sleep Medicine, 4(2), 123-127.

Cartwright, R. D. (1984). Effect of sleep position on sleep apnea severity. Sleep, 7(2), 110-114.

Eckert, D. J., Malhotra, A., Lo, Y. L., White, D. P., & Jordan, A. S. (2007). Pathophysiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society, 4(2), 164-173.

Foster, G. D., Borradaile, K. E., Sanders, M. H., Millman, R., Zammit, G., Newman, A. B., Wadden, T. A., Kelley, D., Wing, R. R., Pi-Sunyer, F. X., Reboussin, D., & Kuna, S. T. (2009). A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study. Archives of Internal Medicine, 169(17), 1619-1626.

Foster, G. D., Sanders, M. H., Millman, R., Zammit, G., Borradaile, K. E., Newman, A. B., ... & Sleep AHEAD Research Group. (2009). Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care, 32(6), 1017-1019.

Foster, G. D., Sanders, M. H., Millman, R., Zammit, G., Borradaile, K. E., Newman, A. B., ... & Sleep AHEAD Research Group of Look AHEAD Research Group. (2009). Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care, 32(6), 1017-1019.

Gotsopoulos, H., Kelly, J. J., & Cistulli, P. A. (2002). Oral appliance therapy reduces blood pressure in obstructive sleep apnea: A randomized, controlled trial. Sleep, 25(5), 543-550.

Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet, 365(9464), 1046-1053.

Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. N. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet, 365(9464), 1046-1053.

Palmer, L. J., Buxbaum, S. G., Larkin, E., Patel, S. R., Elston, R. C., Tishler, P. V., & Redline, S. (2004). Whole genome scan for obstructive sleep apnea and obesity in African-American families. American Journal of Respiratory and Critical Care Medicine, 169(12), 1314-1321.

Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine, 342(19), 1378-1384.

Peppard, P. E., Young, T., Palta, M., Dempsey, J., & Skatrud, J. (2000). Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA, 284(23), 3015-3021.

Redline, S., Tishler, P. V., Hans, M. G., Tosteson, T. D., Strohl, K. P., & Spry, K. (1995). Racial differences in sleep-disordered breathing in African-Americans and Caucasians. American Journal of Respiratory and Critical Care Medicine, 155(1), 186-192.

Schwab, R. J., Pasirstein, M., Pierson, R., Mackley, A., Hachadoorian, R., Arens, R., ... & Pack, A. I. (2003). Identifying upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. American Journal of Respiratory and Critical Care Medicine, 168(5), 522-530.

Schwartz, M. P., & Kirsch, D. B. (2016). Sleep disorders. In E. J. Benjamin (Ed.), Johns Hopkins psychiatry guide. Johns Hopkins University Press.

Sher, A. E., Schechtman, K. B., & Piccirillo, J. F. (1996). The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep, 19(2), 156-177.

Sullivan, C. E., Issa, F. G., Berthon-Jones, M., & Eves, L. (1981). Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. The Lancet, 317(8225), 862-865.

Tregear, S., Reston, J., Schoelles, K., & Phillips, B. (2009). Obstructive sleep apnea and risk of motor vehicle crash: Systematic review and meta-analysis. Journal of Clinical Sleep Medicine, 5(6), 573-581.

Weaver, T. E., Maislin, G., Dinges, D. F., Bloxham, T., George, C. F. P., Greenberg, H., Kader, G., Mahowald, M., Younger, J., & Pack, A. I. (2007). Relationship between hours of CPAP use and achieving normal sleepiness and daily functioning. Sleep, 30(6), 711-719.

Weaver, T. E., Mancini, C., Maislin, G., Cater, J., Staley, B., Landis, J. R., Ferguson, K. A., George, C. F. P., Schulman, D. A., Greenberg, H., Rapoport, D. M., Walsleben, J. A., Lee-Chiong, T., & Kuna, S. T. (2007). Continuous favorable airway pressure treatment of sleepy patients with milder obstructive sleep apnea: Results of the CPAP Apnea Trial North American Program (CATNAP) study. American Journal of Respiratory and Critical Care Medicine, 176(7), 749-755.

Wetter, D. W., Young, T. B., Bidwell, T. R., Badr, M. S., & Palta, M. (1994). Smoking as a risk factor for sleep-disordered breathing. Archives of Internal Medicine, 154(19), 2219-2224.

Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328(17), 1230-1235.

Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. New England Journal of Medicine, 328(17), 1230-1235.

Young, T., Peppard, P. E., & Gottlieb, D. J. (2002). Epidemiology of obstructive sleep apnea: A population health perspective. American Journal of Respiratory and Critical Care Medicine, 165(9), 1217-1239.